Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C5H9O2.Zn |
| Molecular Weight | 267.657 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Zn++].CCCCC([O-])=O.CCCCC([O-])=O
InChI
InChIKey=BUDAIZWUWHWZPQ-UHFFFAOYSA-L
InChI=1S/2C5H10O2.Zn/c2*1-2-3-4-5(6)7;/h2*2-4H2,1H3,(H,6,7);/q;;+2/p-2
| Molecular Formula | Zn |
| Molecular Weight | 65.409 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C5H9O2 |
| Molecular Weight | 101.1238 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Valeric acid is a colorless, oily liquid with an unpleasant odor. It is highly corrosive and must be handled with care. Valeric acid is mainly used as a chemical intermediate to manufacture flavors and perfumes, synthetic lubricants, agricultural chemicals, and pharmaceuticals. It is also used as a flavoring aid in foods. Valeric acid is considered safe as a food additive by the World Health Organization.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids. | 2004-03 |
|
| Sequential feeding of glucose and valerate in a fed-batch culture of Ralstonia eutropha for production of poly(hydroxybutyrate-co-hydroxyvalerate) with high 3-hydroxyvalerate fraction. | 2004-02-07 |
|
| Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. | 2004-01-27 |
|
| The degradability of biodegradable plastics in aerobic and anaerobic waste landfill model reactors. | 2004-01 |
|
| Mecamylamine reduces nicotine cross-desensitization of trigeminal caudalis neuronal responses to oral chemical irritation. | 2003-11-21 |
|
| Ruminal fermentation and bacterial protein synthesis of whole cottonseed coated with combinations of gelatinized corn starch and urea. | 2003-11 |
|
| Pelleted beet pulp substituted for high-moisture corn: 3. Effects on ruminal fermentation, pH, and microbial protein efficiency in lactating dairy cows. | 2003-11 |
|
| Kinetics of thermophilic, anaerobic oxidation of straight and branched chain butyrate and valerate. | 2003-10-20 |
|
| Regulation of glucose-6-phosphatase gene expression in cultured hepatocytes and H4IIE cells by short-chain fatty acids: role of hepatic nuclear factor-4alpha. | 2003-10-17 |
|
| Synthesis, X-ray crystal structure, UV/visible linear and nonlinear (optical limiting) spectral properties of symmetrical and unsymmetrical porphyrazines with annulated 1,2,5-thiadiazole and 1,4-diamyloxybenzene moieties. | 2003-09-05 |
|
| Conformationally constrained analogues of bleomycin A5. | 2003-08-27 |
|
| [Anti-arrhythmia activity of estradiol valerate and estradiol nitrate]. | 2003-08-20 |
|
| Synthesis and cytotoxicity of new platinum(IV) complexes of mixed carboxylates. | 2003-08-01 |
|
| Eubacterium pyruvativorans sp. nov., a novel non-saccharolytic anaerobe from the rumen that ferments pyruvate and amino acids, forms caproate and utilizes acetate and propionate. | 2003-07 |
|
| Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial. | 2003-07 |
|
| Dynamics of the anaerobic process: effects of volatile fatty acids. | 2003-06-30 |
|
| Parameter identification of thermophilic anaerobic degradation of valerate. | 2003-06-10 |
|
| Heterogeneous acylation of flax fibers. Reaction kinetics and surface properties. | 2003-05-14 |
|
| Production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) with high molar fractions of 3-hydroxyvalerate by a threonine-overproducing mutant of Alcaligenes sp. SH-69. | 2003-05 |
|
| Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. | 2003-04-18 |
|
| Activation of neurons in trigeminal caudalis by noxious oral acidic or salt stimuli is not reduced by amiloride. | 2003-04-18 |
|
| Psychophysical evaluation of responses to pleasant and mal-odour stimulation in human subjects; adaptation, dose response and gender differences. | 2003-04 |
|
| Effects of hydrochloric, valeric, and other volatile fatty acids on pathogenesis of ulcers in the nonglandular portion of the stomach of horses. | 2003-04 |
|
| Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia. | 2003-04 |
|
| The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. | 2003-03-28 |
|
| Left ventricular diastolic function assessment by tissue Doppler echocardiography in relation to hormonal replacement therapy in postmenopausal women with diastolic dysfunction. | 2003-03-12 |
|
| Improvement of (+)-catechin inhibitory activity on human PMN respiratory burst by (+)-3-O-propionyl and (-)-3-O-valeryl substitution. | 2003-03 |
|
| Lack of quinine-evoked activity in rat trigeminal subnucleus caudalis. | 2003-03 |
|
| Optimizing the level of wet corn gluten feed in the diet of lactating dairy cows. | 2003-03 |
|
| Polymers for biodegradable medical devices XI. Microencapsulation studies: characterization of hydrocortisone-loaded poly-hydroxybutyrate-hydroxyvalerate microspheres. | 2003-02-06 |
|
| Effect of method of application of a fibrolytic enzyme product on digestive processes and milk production in Holstein-Friesian cows. | 2003-02 |
|
| Enhanced biosynthesis of polyhydroxyalkanoates in a mutant strain of Rhizobium meliloti. | 2003-01 |
|
| Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood. | 2003 |
|
| Liquefaction and methanization of solid and liquid coffee wastes by two phase anaerobic digestion process. | 2003 |
|
| Hydrogen production from wastewater by acidogenic granular sludge. | 2003 |
|
| Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. | 2002-12-31 |
|
| Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients. | 2002-11-20 |
|
| Acylated triterpenoid saponins from the stem bark of Foetidia africana. | 2002-11 |
|
| Enhancement of NGF- and cholera toxin-induced neurite outgrowth by butyrate in PC12 cells. | 2002-10-04 |
|
| Characterization of copolymer hydroxybutyrate/hydroxyvalerate from saponified vernonia, soybean, and "spent" frying oils. | 2002-08-16 |
|
| A novel synthesis of (+)-biotin from L-cysteine. | 2002-08-09 |
|
| Effects of culture conditions on the production of polyhydroxyalkanoates by Azotobacter chroococcum H23 in media containing a high concentration of alpechín (wastewater from olive oil mills) as primary carbon source. | 2002-08-07 |
|
| Controlling deuterium isotope effects in comparative proteomics. | 2002-08-01 |
|
| Influence of yeast culture on ruminal microbial metabolism in continuous culture. | 2002-08 |
|
| Sensitization of trigeminal caudalis neuronal responses to intraoral acid and salt stimuli and desensitization by nicotine. | 2002-08 |
|
| Development of a headspace solid-phase microextraction-gas chromatography-mass spectrometry method for the identification of odour-causing volatile compounds in packaging materials. | 2002-07-19 |
|
| Metabolic characteristics of the faecal microflora in humans from three age groups. | 2002-07 |
|
| Cyproterone acetate could counteract the benefits of estradiol valerate in oophorectomized cholesterol-fed rabbits. | 2002-06-26 |
|
| 1H and (13)C NMR spectroscopic analysis of human saliva. | 2002-06 |
|
| A rapid selective extraction procedure for the outer membrane protein (OmpF) from Escherichia coli. | 2002-06 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:17:10 GMT 2025
by
admin
on
Mon Mar 31 18:17:10 GMT 2025
|
| Record UNII |
HHJ036TQR0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
209-124-1
Created by
admin on Mon Mar 31 18:17:10 GMT 2025 , Edited by admin on Mon Mar 31 18:17:10 GMT 2025
|
PRIMARY | |||
|
68393
Created by
admin on Mon Mar 31 18:17:10 GMT 2025 , Edited by admin on Mon Mar 31 18:17:10 GMT 2025
|
PRIMARY | |||
|
1546360
Created by
admin on Mon Mar 31 18:17:10 GMT 2025 , Edited by admin on Mon Mar 31 18:17:10 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID00890509
Created by
admin on Mon Mar 31 18:17:10 GMT 2025 , Edited by admin on Mon Mar 31 18:17:10 GMT 2025
|
PRIMARY | |||
|
m11634
Created by
admin on Mon Mar 31 18:17:10 GMT 2025 , Edited by admin on Mon Mar 31 18:17:10 GMT 2025
|
PRIMARY | Merck Index | ||
|
HHJ036TQR0
Created by
admin on Mon Mar 31 18:17:10 GMT 2025 , Edited by admin on Mon Mar 31 18:17:10 GMT 2025
|
PRIMARY | |||
|
556-38-7
Created by
admin on Mon Mar 31 18:17:10 GMT 2025 , Edited by admin on Mon Mar 31 18:17:10 GMT 2025
|
PRIMARY | |||
|
100000145791
Created by
admin on Mon Mar 31 18:17:10 GMT 2025 , Edited by admin on Mon Mar 31 18:17:10 GMT 2025
|
PRIMARY | |||
|
HHJ036TQR0
Created by
admin on Mon Mar 31 18:17:10 GMT 2025 , Edited by admin on Mon Mar 31 18:17:10 GMT 2025
|
PRIMARY | |||
|
SUB124575
Created by
admin on Mon Mar 31 18:17:10 GMT 2025 , Edited by admin on Mon Mar 31 18:17:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |